| 000 | 01859 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516050537.0 | ||
| 264 | 0 | _c20120605 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1097-0215 | ||
| 024 | 7 |
_a10.1002/ijc.26324 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQi, Wenqing | |
| 245 | 0 | 0 |
_aAT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomas. _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cJun 2012 |
||
| 300 |
_a2997-3005 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aAurora Kinase B |
| 650 | 0 | 4 | _aAurora Kinases |
| 650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTaxoids _xpharmacology |
| 650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aLiu, Xiaobing | |
| 700 | 1 | _aCooke, Laurence S | |
| 700 | 1 | _aPersky, Daniel O | |
| 700 | 1 | _aMiller, Thomas P | |
| 700 | 1 | _aSquires, Matthew | |
| 700 | 1 | _aMahadevan, Daruka | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 130 _gno. 12 _gp. 2997-3005 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.26324 _zAvailable from publisher's website |
| 999 |
_c21042592 _d21042592 |
||